ANI PHARMACEUTICALS INC
ANIPNASDAQ🏆 #2058 by market capEarnings Nov 5 · PreUS Equity
$73.16▲ $1.45 (+2.02%)
🌙 After hours$73.16▲ 0.00%Regular close · extended-hours price shownTrack ANIP
Get earnings, price moves & breaking news on Telegram
24h▲ 2.0%
7d▲ 0.8%
14d▲ 1.3%
30d▲ 0.6%
ytd▼ 7.4%
1y▼ 20.4%
🏦Market Cap
$1.68B
Small Cap
📈Revenue Growth (YoY)
30.9%
High Growth
📊Gross Margin
60.4%
High
💵FCF Margin
17.7%
Healthy
⚖️P/S Ratio
1.7x
Cheap
Otter Score
80
Strong
ANI PHARMACEUTICALS INC
ANIPAnalyst Ratings
Price
$73.16
Total
10
Raised
1
Lowered
2
Avg PT
$99.50
H / L
$119 / $85
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Guggenheim | Reiterated | Buy | 2026-08-10 | $119.00 | +62.70% |
Canaccord Genuity | Reiterated | Hold | 2026-08-10 | $90.00 | +23.00% |
Truist Securities | Reiterated | Hold | 2025-10-09 | — | — |
JP Morgan | Reiterated | Overweight | 2025-09-24 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2025-09-17 | — | — |
Raymond James | Reiterated | Outperform | 2024-09-18 | $83.00 | +13.40% |
Cantor Fitzgerald | Downgraded | Overweight → Neutral | 2020-05-07 | — | — |
Oppenheimer | Reiterated | Outperform | 2016-08-05 | $85.00 | +16.20% |
Standpoint Research | Downgraded | Buy → Hold | 2016-05-24 | — | — |
Roth Capital | Upgraded | Neutral → Buy | 2015-09-28 | — | — |
Institution
Guggenheim
Reiterated · Buy · 2026-08-10
$119.00
+62.70%
Canaccord Genuity
Reiterated · Hold · 2026-08-10
$90.00
+23.00%
Truist Securities
Reiterated · Hold · 2025-10-09
—
—
JP Morgan
Reiterated · Overweight · 2025-09-24
—
—
HC Wainwright & Co.
Reiterated · Buy · 2025-09-17
—
—
Raymond James
Reiterated · Outperform · 2024-09-18
$83.00
+13.40%
Cantor Fitzgerald
Downgraded · Overweight → Neutral · 2020-05-07
—
—
Oppenheimer
Reiterated · Outperform · 2016-08-05
$85.00
+16.20%
Standpoint Research
Downgraded · Buy → Hold · 2016-05-24
—
—
Roth Capital
Upgraded · Neutral → Buy · 2015-09-28
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space